Welcome to Clearing the Haze, On this week's podcast, we uncover groundbreaking advancements in drug testing and workplace safety. In today's episode, we have the privilege of interviewing the brilliant minds behind Buzzkill Labs, a company revolutionizing how we approach drug detection and quantitation.
Buzzkill Labs is at the forefront of developing next-generation technology, merging patented noninvasive sample collection methodology with scientifically validated laboratory techniques. Their innovative products address pressing needs in various sectors, including workplace safety, law enforcement's battle against impaired driving, and fast, accurate testing in medical and drug treatment centers.
If you're an employer or work with clients grappling with the decision to test for marijuana in the workplace, this episode is an absolute must-listen. Join us as we delve into an enlightening conversation with Buzzkill's CEO, Jeff Heimburger, and CTO, Dr. George Farquar. They will unveil the game-changing technology they've created and discuss how it's poised to make a monumental impact on the landscape of workplace drug testing.
To learn more about Buzzkill Labs and their groundbreaking solutions, visit buzzkilllabs.com.
For inquiries, reach out to [email protected].
You can also connect directly with
Jeff Heimburger at [email protected] and
Dr. George Farquar at [email protected].
Jeff brings over two decades of experience leading organizations within industry giants like Abbott, Roche, Agilent, and Focus Diagnostics, to name a few. His expertise extends to startups acquired by Thermo Fisher and Danaher, where he spearheaded commercial teams in the forensic and diagnostic markets. With an educational background in mechanical engineering and biology from Purdue University, Jeff has successfully launched numerous products worldwide for both global molecular diagnostics leaders and groundbreaking innovators.
Dr. George Farquar, Buzzkill's esteemed CTO, is no stranger to entrepreneurial success. His visionary ideas have resulted in the founding of three companies, and in 2013, he earned an R&D 100 award for a biothreat detection technology still utilized worldwide today. George holds a PhD in Physical Chemistry from LSU and has led research teams at prestigious institutions such as Oakridge and Lawrence Livermore National Laboratories.
Get ready to explore a future where drug testing and workplace safety take a giant leap forward. Let's dive into this enlightening conversation with Buzzkill Labs!